D
deckard
For a few years now I have been following development of a new type of 100% artificial, trileaflet heart valve that is intended to last a lifetime, yet require no anti-coagulants. The valve uses a new co-polymer (silicone-polyurethane) called Elast-Eon, developed over many years by an Australian company called Aortech. I read that one grade of Elast-Eon has already been approved by FDA for use in pacemaker leads which St Jude Medical has an exclusive supply agreement for. Percardia and Abbot Laboratories (for stent manufacture) also have agreements with Aortech regarding medical devices using Elast-Eon. The most lucrative use of Elast-Eon will be for heart valves and breast implants. Elast-Eon breast implants are currently pending approval by FDA. Aortech is currently doing pre-clinical development of their trileaflet valve designs for use in surgical, percutaneous and interventional valve replacement. The designs have been granted patents by the European Patent Office. And a percutaneous valve was presented to positive response in March 2006 at the Transcatheter Symposium in Washington D.C.